CDNA

CareDx Inc.

Price

$46.51

return (12m)

301.99%

p/e

20.92

p/bv

5.46

DIVIDEND YIELD

0.00%

CDNA price

CareDx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CDNA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

20.34%

3 months

115.62%

1 year

301.99%

2 years

36.83%

5 years

-36.72%

10 years

900.22%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CDNA

Valuation

P/E

20.92

Sector -4.38

Industry -4.38

P/BV

5.46

Sector 2.02

Industry 2.02

P/Revenue (PSR)

5.07

Sector -4.40

Industry -4.40

EV/EBITDA

452.30

Sector -263.09

Industry -263.09

EV/EBIT

7,497.73

Sector -702.90

Industry -702.90

P/EBITDA

226.64

Sector -4.39

Industry -4.39

P/EBIT

-549.18

Sector -4.73

Industry -4.73

P/Total Assets

4.36

Sector 1.49

Industry 1.49

P/Net Current Assets

7.22

Sector -11.70

Industry -11.70

P/Working Capital

6.92

Sector -3.19

Industry -3.19

EPS

2.18

Sector -2.14

Industry -2.14

BVPS

8.35

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

70.58%

Sector 36.74%

Industry 36.74%

EBITDA Margin

3.27%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

0.20%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-0.92%

Sector -38.22%

Industry -38.22%

Net Profit Margins

24.23%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.25

Sector 0.03

Industry 0.03

Profitability

ROE

26.09%

Sector -65.14%

Industry -65.14%

ROA

20.83%

Sector -65.53%

Industry -65.53%

ROIC

0.61%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

4.58

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-86.69

Sector -6.07

Industry -6.07

Net Debt / EBIT

-1,437.08

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.88

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.80

Sector 0.41

Industry 0.41

Liabilities/Assets

0.20

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

9.10%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF CareDx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$46.51

Fair Value

$20.24

Upside Return potential.

-56.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals CDNA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CDNA CareDx Inc.	$46.51	292.49%	0.00%	20.92	5.46	26.09%	24.23%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CDNA Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT CareDx

CareDx Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2014

Time since IPO - 12 years

386

Employees

CareDx Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.32 billion, with shareholders equity totaling $425.60 million.

The company employs approximately 386 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, CareDx Inc. reported $458.10 million in revenue, generating net income of $111.02 million.

Key financial metrics include a P/E ratio of 20.92, a price-to-book (P/B) ratio of 5.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CDNA.

Market cap

$2.32 billion

Net worth

$425.60 million

$425,600,000.00

Assets

$532.99 million

$532,990,000.00

Total Shares Outstanding

51.00 million

51,000,000

Average Daily Trading Volume

$1.11 million

$1,112,188.00

Sector

Health Care

Industry

Biotechnology

CDNA

CDNA revenue and profits

Financial Results CDNA

DRAG THE FRAME TO SEE MORE DATA

CDNA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of CareDx (CDNA) today?

A cotação de CareDx (CDNA) hoje está em US$ 46.51, com uma variação de 301.99% em relação ao último ano. A cotação de CareDx (CDNA) iniciou o ano negociando na casa dos US$ 18.84 e hoje está em US$ 46.51. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de CareDx (CDNA) e dados de ações do Ibovespa e mercados internacionais.

Quando CareDx (CDNA) paga dividendos?

CareDx (CDNA) não distribuiu dividendos no último ano.

Is CareDx (CDNA) a good investment?

Atualmente, CareDx (CDNA) está cotada a US$ 46.51, com um P/L de 20.92, representando um desvio de -285% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 301.99 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 301.99%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy CareDx (CDNA) stock?

Investir em ações de CareDx (CDNA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of CareDx (CDNA) yield today?

A rentabilidade de CareDx (CDNA) foi de 20.34% no último mês, 301.99% no último ano e -36.72% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de CareDx (CDNA) hoje, o investimento total seria de US$ 4,651.00, com base na cotação atual de US$ 46.51.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 18,696.55
Em 5 anos: US$ 2,943.15
Em 10 anos: US$ 46,520.23

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CDNA

CareDx Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CDNA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING CDNA WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT CareDx

CareDx Inc.

United States

28 years

2014

386

PROFIT X PRICE CDNA

Financial Results CDNA

CDNA cash flow

Asset, Revenue and Profit Growth - CDNA

CDNA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions